BIXT
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
7M
WVE
Price
$9.60
Change
-$0.33 (-3.32%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
1.58B
69 days until earnings call
Interact to see
Advertisement

BIXT vs WVE

Header iconBIXT vs WVE Comparison
Open Charts BIXT vs WVEBanner chart's image
Bioxytran
Price$0.08
Change-$0.00 (-0.00%)
Volume$48.95K
Capitalization7M
Wave Life Sciences
Price$9.60
Change-$0.33 (-3.32%)
Volume$47.45K
Capitalization1.58B
BIXT vs WVE Comparison Chart in %
Loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIXT vs. WVE commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIXT is a Hold and WVE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (BIXT: $0.08 vs. WVE: $9.93)
Brand notoriety: BIXT and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIXT: 59% vs. WVE: 94%
Market capitalization -- BIXT: $7M vs. WVE: $1.58B
BIXT [@Biotechnology] is valued at $7M. WVE’s [@Biotechnology] market capitalization is $1.58B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIXT’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • BIXT’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, WVE is a better buy in the long-term than BIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIXT’s TA Score shows that 5 TA indicator(s) are bullish while WVE’s TA Score has 4 bullish TA indicator(s).

  • BIXT’s TA Score: 5 bullish, 4 bearish.
  • WVE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BIXT is a better buy in the short-term than WVE.

Price Growth

BIXT (@Biotechnology) experienced а -1.62% price change this week, while WVE (@Biotechnology) price change was +1.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

WVE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.58B) has a higher market cap than BIXT($7M). BIXT YTD gains are higher at: -12.458 vs. WVE (-19.725). BIXT has higher annual earnings (EBITDA): -1.68M vs. WVE (-134.84M). WVE has more cash in the bank: 208M vs. BIXT (3.14K). BIXT has less debt than WVE: BIXT (1.35M) vs WVE (21.7M). WVE has higher revenues than BIXT: WVE (93.9M) vs BIXT (0).
BIXTWVEBIXT / WVE
Capitalization7M1.58B0%
EBITDA-1.68M-134.84M1%
Gain YTD-12.458-19.72563%
P/E RatioN/AN/A-
Revenue093.9M-
Total Cash3.14K208M0%
Total Debt1.35M21.7M6%
FUNDAMENTALS RATINGS
BIXT vs WVE: Fundamental Ratings
BIXT
WVE
OUTLOOK RATING
1..100
1973
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
9293
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8538
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5041

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WVE's Valuation (63) in the Biotechnology industry is in the same range as BIXT (84) in the null industry. This means that WVE’s stock grew similarly to BIXT’s over the last 12 months.

BIXT's Profit vs Risk Rating (92) in the null industry is in the same range as WVE (93) in the Biotechnology industry. This means that BIXT’s stock grew similarly to WVE’s over the last 12 months.

BIXT's SMR Rating (100) in the null industry is in the same range as WVE (100) in the Biotechnology industry. This means that BIXT’s stock grew similarly to WVE’s over the last 12 months.

WVE's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for BIXT (85) in the null industry. This means that WVE’s stock grew somewhat faster than BIXT’s over the last 12 months.

WVE's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BIXT (100) in the null industry. This means that WVE’s stock grew similarly to BIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIXTWVE
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LAUR27.550.21
+0.77%
Laureate Education
HEI318.071.51
+0.48%
HEICO Corp
EMBC14.50-0.09
-0.62%
Embecta Corp
CRBU1.94-0.04
-2.02%
Caribou Biosciences
LIQT1.88-0.05
-2.84%
LiqTech International

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CCCC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
N/A
CCCC - BIXT
22%
Poorly correlated
-1.16%
IMUX - BIXT
22%
Poorly correlated
+1.77%
WVE - BIXT
20%
Poorly correlated
-1.49%
DOMH - BIXT
20%
Poorly correlated
-3.40%
BSEM - BIXT
11%
Poorly correlated
+14.42%
More